Treatment of opioid-dependent pregnant women: clinical and research issues. - Wikidata - wikimedia - TriplyDB

Treatment of opioid-dependent pregnant women: clinical and research issues.

Treatment of opioid-dependent pregnant women: clinical and research issues.

http://www.wikidata.org/entity/Q37076673

about

Maintenance agonist treatments for opiate-dependent pregnant women Neonatal abstinence syndrome after methadone or buprenorphine exposure Chronic in utero buprenorphine exposure causes prolonged respiratory effects in the guinea pig neonate.Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Postpartum changes in methadone maintenance dose Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women Recent sex trade and injection drug use among pregnant opiate and cocaine dependent women in treatment: The significance of psychiatric comorbidity.Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment.Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes.Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women.Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples.Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study.Fetal neurobehavioral effects of exposure to methadone or buprenorphine.Unintended pregnancy in opioid-abusing women.The management of opioid dependence during pregnancy in rural and remote settings Initial feasibility of a woman-focused intervention for pregnant african-american women.Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes.Neonatal neurobehavior effects following buprenorphine versus methadone exposure.Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant Patients.Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone.Auricular acupuncture for chemically dependent pregnant women: a randomized controlled trial of the NADA protocol Systematic Review of Interventions for Racial/Ethnic-Minority Pregnant Smokers Case Presentations from the Addiction Academy.Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics.The treatment of alcohol and opioid dependence in pregnant women.Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population Psychopharmacologic management of opioid-dependent women during pregnancy.Increasing pregnancy-related use of prescribed opioid analgesics Evaluation and management of opioid dependence in pregnancy Buprenorphine for the treatment of perinatal opioid dependence: pharmacology and implications for antepartum, intrapartum, and postpartum care.Buprenorphine use in pregnant opioid users: a critical review.Pharmacological Management of Opioid Use Disorder in Pregnant Women.Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.

P2860

Q24201642-C4965B48-C9F2-4D76-8A5F-0D08833532A1 Q30499416-D046E977-2695-41A7-887C-0F862754373F Q33787848-CC151581-9660-4E1A-8A3C-F20A023240FA Q33807411-DCF96791-7077-4631-A442-9319F1A27CE4 Q33862878-3E53B194-49F0-4D4A-BBA2-82ADE8F62408 Q33870389-5E17F461-96E9-4B3E-8A34-449BA591C0AF Q33954082-68A3F139-42A2-47ED-B18F-C36D6F4FE426 Q34000757-0F54D796-55FF-4134-A8E2-05B79B62D177 Q34018737-FB75E587-BC3C-4FBB-AAAE-8F9D14D8F690 Q34051048-EBB6461F-981E-4717-98C5-553AE177E929 Q34065531-0D277325-CA53-45A9-BDED-C9252E68960C Q34076552-F29903B4-15D0-4E52-A27E-E5AE4918BFA1 Q34078498-53B6FF85-F03A-42CE-92F4-9D9B1730404D Q34078533-2EA203DB-786A-4669-9FB4-32F2D486729E Q34581552-9FF35FDC-6CDB-4BB6-A60C-BC5BBD350F02 Q34644427-F408ECA4-FE3D-402C-BF4D-DB21C8B2D863 Q34825515-503DD273-86B9-4C21-8121-14A3CEE12E7A Q34877114-EF6DFEE4-F009-4A9B-8ADC-DF148A72D38E Q35023911-67A3AD9D-7F75-400A-BE03-C560532E35B9 Q35044036-DA70437A-8C97-4691-8F2C-058207506929 Q35112402-7D679C6E-0D5E-4244-BA4E-68B1ACCC3799 Q35286458-72B8BAEB-A6EC-4785-AF19-82721DA7F188 Q35621921-8924D4CF-7D67-413C-8F00-DBD7B6827E1B Q35863900-2F0890EC-8D45-4E12-A49E-B1FD3FD73E21 Q36107343-693C2E8C-4461-4904-9821-83467ED0EBC8 Q36165912-615EDC15-FCDB-459F-BB01-EB92B4036B20 Q36581597-5D2C3A6D-1C58-44AD-A6E0-4604FE41647D Q36608705-AE8A929A-461F-49F6-A516-E9C625A3DB79 Q36660807-44477303-6F79-499F-8640-96206483790F Q36966035-AC0460B6-2FC8-4427-94C9-AAD0C1DC7509 Q37157271-6F2669A9-FCD0-4386-AD66-8D67D6DC2FF4 Q37351683-C2EDEA63-330F-4E01-9CC7-BC5C42DF096B Q37390027-60D04317-305C-4184-B052-4911291245B8 Q37421838-EF124382-F2A5-40C9-84BB-847043C2804D Q37464251-BA57C5AB-B9AF-409B-8699-00057401879B Q37632852-64994666-8B6B-43FA-B5F9-4F369BC954FB Q37871042-4E7378BD-F5E0-4E5A-B5A5-D32B01953A18 Q38115201-99FA00F6-6712-49AA-B378-45ED1B95407C Q38575591-A7D578B2-1D67-456F-9B84-A6FCCA39E73E Q38689763-6D62A105-C9B5-4770-B986-9ADD40B7B14F

P2860

Treatment of opioid-dependent pregnant women: clinical and research issues.

http://www.wikidata.org/entity/Q37076673

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treatment of opioid-dependent pregnant women: clinical and research issues.

@en

Treatment of opioid-dependent pregnant women: clinical and research issues.

@nl

type

label

Treatment of opioid-dependent pregnant women: clinical and research issues.

@en

Treatment of opioid-dependent pregnant women: clinical and research issues.

@nl

prefLabel

Treatment of opioid-dependent pregnant women: clinical and research issues.

@en

Treatment of opioid-dependent pregnant women: clinical and research issues.

@nl

P1433

Q37076673-FE046B8C-D2AA-4A3D-9BA5-95A32D5C4586

P1476

Q37076673-C5149F96-935A-492D-946D-2E15F27BFF56

P2093

Q37076673-0A3CAE02-F17E-400F-B73E-0A20DF0F4482

Q37076673-3F072E62-8B51-4F63-8C7B-4B7FB7569855

Q37076673-46DE5F4C-5D67-4486-9EBC-BA13C3C7B696

Q37076673-79AD2676-4605-48BD-B3C1-25099FD44036

Q37076673-A55E676C-E151-4C4C-9498-6D58C23C82B1

Q37076673-B15513C1-5934-4C03-8D43-D92FC10D299E

Q37076673-E5BC1464-5974-4C0D-9050-2493A9F33530

Q37076673-E7C35EE1-A92B-4B34-8C55-ED31EA20B4CD

P2860

Q37076673-0027BAB3-694E-4E57-B078-69C3BEAAF35B

Q37076673-04C40230-3FB9-4F35-9F58-C1D42AC2640B

Q37076673-0962BE73-E43C-4DAC-9339-8FC709FECCED

Q37076673-09B22CBB-3F90-4CFA-A285-9EC524DB42D7

Q37076673-0B46D00E-F7EE-4CEE-8C33-E7D5A6CAB6A6

Q37076673-0C39D0B6-02DB-48CB-A976-A7E3E5D93A07

Q37076673-0E6E8D09-EF46-4AE0-B9FD-53563D4977BC

Q37076673-114C5760-DE24-40BF-BAD0-577D53E2F6BB

Q37076673-119DEEF2-AF82-4635-8008-4E01B4F3A2EC

Q37076673-13EBB197-2BE9-4801-97A6-AB5EF45E7457

P304

Q37076673-C9ED021C-8AC0-44B6-AD2A-9E71ECFAF829

P31

Q37076673-F66393BA-7353-41F6-9B0A-1E8A16E141B2

P356

Q37076673-21BCA917-3AB8-476E-BBE4-60780E675864

P433

Q37076673-20ABC010-25E9-4148-AEB4-D0D35172885B

P478

Q37076673-24C99DB5-168F-40A3-81ED-CF7016B25A2A

P50

Q37076673-05481C41-3C80-4AA3-8637-C7F6EB4F538B

Q37076673-6CDC0EF4-2721-42ED-8AD3-A089B0A9BCC9

P577

Q37076673-D7ECCE83-E3B7-4350-81E2-04851F0C5E39

P5875

Q37076673-D6D0FD29-9EDD-44EE-9ED1-A580E537F309

P698

Q37076673-3480A96E-6D70-4611-A629-4982AA3EC996

P921

Q37076673-2D1C2052-05F2-43F7-9DDB-CE9E9611885D

Q37076673-B3247ADE-85DF-4875-90BD-9004B4221E89

P932

Q37076673-E6DA0A9A-CFDD-421C-AC2E-5EB5ABA0D0E3

P356

J.JSAT.2007.10.007

P1433

Journal of Substance Abuse Treatment

P1476

Treatment of opioid-dependent pregnant women: clinical and research issues.

@en

P2093

Gabriele Fischer

http://www.w3.org/2001/XMLSchema#string

Hendree E Jones

http://www.w3.org/2001/XMLSchema#string

Karol Kaltenbach

http://www.w3.org/2001/XMLSchema#string

Kevin E O'Grady

http://www.w3.org/2001/XMLSchema#string

Mara G Coyle

http://www.w3.org/2001/XMLSchema#string

Peter R Martin

http://www.w3.org/2001/XMLSchema#string

Peter Selby

http://www.w3.org/2001/XMLSchema#string

Sarah H Heil

http://www.w3.org/2001/XMLSchema#string

P2860

Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation

Assessing the needs of substance abusing women. Psychometric data on the psychosocial history.

Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.

Mechanisms of fatal opioid overdose.

[Drug interactions with methadone].

The accelerated intake: a method for increasing initial attendance to outpatient cocaine treatment

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.

A meta-analysis of voucher-based reinforcement therapy for substance use disorders.

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

P304

245-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSAT.2007.10.007

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Amelia M. Arria

P577

2008-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5603325

http://www.w3.org/2001/XMLSchema#string

P698

18248941

http://www.w3.org/2001/XMLSchema#string

P921

P932

2633026

http://www.w3.org/2001/XMLSchema#string